Novità da Vivetus®

Vivetus NMN and resveratrol supplement bundle

Raise Blood NAD+ in 4–8 Weeks with NMN: Trial E...

Evidence first: NMN raises blood NAD+ in 4 to 8 weeks; resveratrol shows metabolic benefits. Trial based dosing, safety notes, and Vivetus product options.

Raise Blood NAD+ in 4–8 Weeks with NMN: Trial E...

Evidence first: NMN raises blood NAD+ in 4 to 8 weeks; resveratrol shows metabolic benefits. Trial based dosing, safety notes, and Vivetus product options.

Vivetus quercetin product beside bromelain capsules

15× higher quercetin exposure: Dutch take on br...

Balanced, Netherlands-aware review of quercetin and bromelain: what human trials show for allergy and recovery, how formulation can boost quercetin up to...

15× higher quercetin exposure: Dutch take on br...

Balanced, Netherlands-aware review of quercetin and bromelain: what human trials show for allergy and recovery, how formulation can boost quercetin up to...

Vivetus berberine beside an evening dinner

500 mg With Dinner: Safer Berberine Use Before ...

For readers in the Netherlands: take berberine before bed only with dinner. Prefer 500 mg as part of a 1,000–1,500 mg per day split, and check drug...

500 mg With Dinner: Safer Berberine Use Before ...

For readers in the Netherlands: take berberine before bed only with dinner. Prefer 500 mg as part of a 1,000–1,500 mg per day split, and check drug...

Vivetus resveratrol quercetin supplement bundle

Resveratrol and Quercetin: 68% Cut in Lipid Dam...

Review the trial behind a 68% fall in exercise lipid damage and learn why absorption and CYP drug interactions decide whether resveratrol plus quercetin...

Resveratrol and Quercetin: 68% Cut in Lipid Dam...

Review the trial behind a 68% fall in exercise lipid damage and learn why absorption and CYP drug interactions decide whether resveratrol plus quercetin...

Pharmacist reviewing supplement medication combination

40% Drug Rise in Trial: Berberine Interactions ...

A two week trial found berberine raised a CYP3A4 marker about 40% and reduced CYP2D6. See which medicines are risky and what monitoring helps.

40% Drug Rise in Trial: Berberine Interactions ...

A two week trial found berberine raised a CYP3A4 marker about 40% and reduced CYP2D6. See which medicines are risky and what monitoring helps.

Older adult discussing health monitoring with clinician

Monitor These Labs on Long Term Berberine for H...

Evidence first guide for health minded adults on long term berberine: six month trial limits, key interaction risks, dosing notes, and which labs to monitor.

Monitor These Labs on Long Term Berberine for H...

Evidence first guide for health minded adults on long term berberine: six month trial limits, key interaction risks, dosing notes, and which labs to monitor.